Yosuke Yamamoto
Director @ Universal Materials Incubator
Yosuke Yamamoto is a Series B investor at Universal Materials Incubator focused on Biotechnology and Chemical. Yosuke Yamamoto - Director @ Universal Materials Incubator
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Yosuke Yamamoto invests in
Stages Yosuke Yamamoto invests in
Countries Yosuke Yamamoto invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 3 (60%)
- Chemical 2 (40%)
- Medical 1 (20%)
- Analytics 1 (20%)
- Life Science 1 (20%)
Stage
- Series B 2 (40%)
- Seed 1 (20%)
- Pre-Seed 1 (20%)
- Series A 1 (20%)
Country
- Japan 2 (40%)
- United States 2 (40%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
iMicrobes
|
Industrial Microbes designs and builds microbes that produce better chemicals with lower costs and lower carbon emissions. We use greenhouse gases as the raw materials, including biogas, natural gas, and carbon dioxide. We scale our process with global chemical producers. | $10M / Seed / Nov 19, 2024 | |
BitBiome
|
BitBiome is a biotechnology company focused on analyzing microbial genomes and discovering enzymes and proteins that can be applied across industries such as pharmaceuticals, food production, and sustainable manufacturing. The company uses single-cell microbial sequencing technology to study microbes that are difficult to culture throughconventional laboratory methods, enabling the creation of a large microbial genome database called bit-GEM. Its platform supports enzyme discovery, genome analysis, and bioengineering efforts aimed at developing bio-based alternatives for industrial processes. bitBiome also works with academic institutions and commercial partners on research projects involving areas such as biodegradable materials, biomass conversion, and pharmaceutical ingredient synthesis. The company positions microbes as a resource for advancing the bioeconomy by providing tools and data that support biotechnology research and industrial applications. | $2.8M / Series B / Jul 31, 2023 | |
Arzeda
|
Arzeda develops innovative products powered by its Intelligent Protein Design Technology, using generative AI-driven design to create, validate, and manufacture new proteins and enzymes that enhance our lives and protect our planet. Arzeda commercializes with Fortune 500 go-to-market partners across multiple industries, enabling higher-performing,more cost-effective solutions that are healthier and sustainable. | $36.7M / Series B / Mar 29, 2022 | |
Alphatech
|
Alphatech is a food tech company that engages in the production of pregelatinized rice flour using a temperature-controlled grinding system. | Pre-Seed / Sep 03, 2020 | |
|
Arzeda
|
Arzeda develops innovative products powered by its Intelligent Protein Design Technology, using generative AI-driven design to create, validate, and manufacture new proteins and enzymes that enhance our lives and protect our planet. Arzeda commercializes with Fortune 500 go-to-market partners across multiple industries, enabling higher-performing,more cost-effective solutions that are healthier and sustainable. | $3.2M / Series A / Nov 29, 2017 |
Co-Investors
Universal Materials Incubator Co., Ltd. is venture capital firm specializing in materials and chemical industry investments. The firm was established on October, 2015 and is headquartered in Tokyo, Japan
Universal Materials Incubator Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Yosuke Yamamoto
Director
|
|||
|
Shosuke Kiba
Founder, CEO & Managing Partner
|
|||
Wataru Mizutani
Principal
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Yosuke Yamamoto invest in?
Yosuke Yamamoto invests primarily in Biotechnology, Chemical and Medical startups, most often at Series B and Seed stage. Most of the 5 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Yosuke Yamamoto?
Public channels for Yosuke Yamamoto include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Yosuke Yamamoto last invest?
The most recent investment recorded for Yosuke Yamamoto closed in Nov 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
